head and neck cancer

ASCO 2023 – Bicara eyes head and neck niche
EP Vantage
Mon, 06/5/23 - 09:59 am
ASCO 2023
Bicara Therapeutics
BCA101
head and neck cancer
Eyeing untapped niche, EpicentRx makes case for cancer toxicity prevention drug
Fierce Biotech
Fri, 01/20/23 - 10:40 am
EpicentRx
clinical trials
head and neck cancer
oral mucositis
RRx-001
Cue's IL-2-based Biologic Shows Early Promise in Head and Neck Cancer
BioSpace
Sun, 11/13/22 - 07:06 pm
Cue Biopharma
CUE-101
head and neck cancer
ESMO: Merck's Keytruda chalks up failure in head and neck cancer. But experts see silver lining
Fierce Pharma
Mon, 09/12/22 - 10:52 am
Merck
Keytruda
head and neck cancer
ESMO
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
Yahoo Finance
Fri, 09/9/22 - 11:03 am
ESMO
Adaptimmune
clinical trials
ADP-A2M4CD8
ovarian cancer
head and neck cancer
urothelial cancer
Merck’s Keytruda fails head and neck cancer trial
CNBC
Wed, 07/20/22 - 09:44 am
Merck
Keytruda
head and neck cancer
clinical trials
Galera's stock plunges 73% on disappointing test results for lead cancer drug candidate
Bizjournals
Tue, 10/19/21 - 10:53 am
Galera Therapeutics
cancer
clinical trials
head and neck cancer
oral mucositis
GC4419
Bristol Myers Squibb takes another late-stage loss for Opdivo-Yervoy combo in head and neck cancer
Endpoints
Fri, 07/16/21 - 10:55 am
Bristol Myers Squibb
Opdivo
head and neck cancer
clinical trials
Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway
Fierce Biotech
Tue, 06/29/21 - 11:03 am
Cel-Sci
immunotherapy
clinical trials
head and neck cancer
Multikine
AstraZeneca's Imfinzi Fails To Prolong Survival In Late-Stage Head And Neck Cancer Study
Benzinga
Fri, 02/5/21 - 10:46 am
AstraZeneca
head and neck cancer
Imfinzi
clinical trials
ALX Oncology Pairs Lead Asset with Keytruda in HNSCC Study
BioSpace
Tue, 09/22/20 - 12:06 pm
ALX Oncology
Merck
head and neck cancer
ALX148
Keytruda
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
Fierce Pharma
Sat, 09/19/20 - 09:20 pm
ESMO
Pfizer
Merck KGaA
Bavencio
head and neck cancer
clinical trials
FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer
Stat
Fri, 06/12/20 - 08:11 pm
Merck
FDA
vaccines
Gardasil 9
head and neck cancer
HPV
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Endpoints
Fri, 03/13/20 - 11:15 am
Merck KGaA
Pfizer
Bavencio
clinical trials
head and neck cancer
After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful
Fierce Biotech
Tue, 02/18/20 - 10:55 am
ALX Oncology
fast rack
FDA
head and neck cancer
ALX148
gastric cancer
Another cancer vaccine play out of Geneva shoots for 'hard endpoint' in PhII head and neck cancer test
Endpoints
Tue, 11/26/19 - 10:32 am
MaxiVAX
cancer
vaccines
cancer vaccines
solid tumors
head and neck cancer
Merck's Keytruda wins FDA approval to treat head and neck cancer
Yahoo/Reuters
Tue, 06/11/19 - 09:31 am
Merck
FDA
head and neck cancer
BMS' head and neck cancer hopes take a hit with Opdivo-Yervoy trial flop
Fierce Pharma
Thu, 04/25/19 - 12:01 pm
Bristol-Myers Squibb
head and neck cancer
Opdivo
Yervoy
FDA promises speedy review on moving Merck's Keytruda up as first-line head and neck cancer therapy
Endpoints
Mon, 02/11/19 - 10:24 am
Merck
Keytruda
FDA
head and neck cancer
priority review
AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer
Fierce Pharma
Fri, 12/7/18 - 12:09 pm
AstraZeneca
Imfinzi
head and neck cancer
clinical trials

Pages